 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
| «12...21222324252627282930313233 |
- | GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
New P1 trial, P1 data: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) - May 3, 2017
P1, N=36, Not yet recruiting, Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation